journal article·2015-12Open access

Surface chemistry regulates valvular interstitial cell differentiation in vitro

Matthew N. Rush, Kent E. Coombs, Elizabeth L. Hedberg-Dirk

Acta Biomaterialia· Volume 28

Abstract

The primary driver for valvular calcification is the differentiation of valvular interstitial cells (VICs) into a diseased phenotype. However, the factors leading to the onset of osteoblastic-like VICs (obVICs) and resulting calcification are not fully understood. This study isolates the effect of substrate surface chemistry on in vitro VIC differentiation and calcified tissue formation. Using ω-functionalized alkanethiol self-assembled monolayers (SAMs) on gold [CH3 (hydrophobic), OH (hydrophilic), COOH (COO(-), negative at physiological pH), and NH2 (NH3(+), positive at physiological pH)], we have demonstrated that surface chemistry modulates VIC phenotype and calcified tissue deposition independent of osteoblastic-inducing media additives. Over seven days VICs exhibited surface-dependent differences in cell proliferation (COO(-)=NH3(+)>OH>CH3), morphology, and osteoblastic potential. Both NH3(+)and CH3-terminated SAMs promoted calcified tissue formation while COO(-)-terminated SAMs showed no calcification. VICs on NH3(+)-SAMs exhibited the most osteoblastic phenotypic markers through robust nodule formation, up-regulated osteocalcin and α-smooth muscle actin expression, and adoption of a round/rhomboid morphology indicative of osteoblastic differentiation. With the slowest proliferation, VICs on CH3-SAMs promoted calcified aggregate formation through cell detachment and increased cell death indicative of dystrophic calcification. Furthermore, induction of calcified tissue deposition on NH3(+) and CH3-SAMs was distinctly different than that of media induced osteoblastic VICs. These results demonstrate that substrate surface chemistry alters VIC behavior and plays an important role in calcified tissue formation. In addition, we have identified two novel methods of calcified VIC induction in vitro. Further study of these environments may yield new models for in vitro testing of therapeutics for calcified valve stenosis, although additional studies need to be conducted to correlate results to in vivo models. Statement of significance Valvular interstitial cell (VIC) differentiation and aortic valve calcification is associated with increased risk of mortality and onset of other cardiovascular disorders. This research examines effects of in vitro substrate surface chemistry on VIC differentiation and has led to the identification of two materials-based initiation mechanisms of osteoblastic-like calcified tissue formation independent of soluble signaling methods. Such findings are important for their potential to study signaling cascades responsible for valvular heart disease initiation and progression as well providing in vitro disease models for drug development. We have also identified a VIC activating in vitro environment that does not exhibit confluence induced nodule formation with promise for the development of tissue regenerating scaffolds.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cardiac Valve Diseases and Treatments · Parathyroid Disorders and Treatments · Dermatological and Skeletal Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (60)

Show source-provided references
1. American Heart Association Statistics C, Stroke Statistics S. Heart disease and stroke statistics – 2014 update: a report from the American Heart Association
2. Burden of valvular heart diseases: a population-based study10.1016/S0140-6736(06)69208-8 ↗
3. Valvular heart disease10.1056/NEJM199707033370107 ↗
4. Calcific aortic stenosis: another face of atherosclerosis?10.3949/ccjm.70.5.471 ↗
5. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops10.1016/j.carpath.2012.06.005 ↗
6. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix10.1161/ATVBAHA.108.182394 ↗
7. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease-2011 update10.1161/CIRCULATIONAHA.110.006767 ↗
8. Substrate properties influence calcification in valvular interstitial cell culture
9. Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression10.1161/ATVBAHA.109.195271 ↗
10. Progression of aortic valve stenosis: TGF-beta 1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis10.1016/S0003-4975(02)04312-6 ↗
11. Transforming growth factor-beta 1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events10.1016/j.athoracsur.2006.10.026 ↗
12. Small peptide functionalized thiol-ene hydrogels as culture substrates for understanding valvular interstitial cell activation and de novo tissue deposition10.1016/j.actbio.2012.05.009 ↗
13. Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels10.1016/j.actbio.2013.04.050 ↗
14. Dynamic stiffening of poly(ethylene glycol)-based hydrogels to direct valvular interstitial cell phenotype in a three-dimensional environment10.1016/j.biomaterials.2015.01.047 ↗
15. Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus
16. Three-dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells10.1016/j.actbio.2013.12.005 ↗
17. Role of the MAPK/ERK pathway in valvular interstitial cell calcification10.1152/ajpheart.00099.2009 ↗
18. Regulation of valvular interstitial cell calcification by adhesive peptide sequences10.1002/jbm.a.32660 ↗
19. Regulation of valvular interstitial cell calcification by components of the extracellular matrix10.1002/jbm.a.32187 ↗
20. Opposite effects of transforming growth factor-beta 1 and vascular endothelial growth factor on the degeneration of aortic valvular interstitial cell are modified by the extracellular matrix protein fibronectin: implications for heart valve engineering10.1089/ten.tea.2010.0304 ↗
21. Manipulation of valve composition to elucidate the role of collagen in aortic valve calcification10.1186/1471-2261-14-29 ↗
22. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology10.2353/ajpath.2007.070251 ↗
23. Cadherin-11 regulates cell–cell tension necessary for calcific nodule formation by valvular myofibroblasts10.1161/ATVBAHA.112.300278 ↗
24. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury10.1016/S1357-2725(96)00117-3 ↗
25. Bone formation and inflammation in cardiac valves10.1161/01.CIR.103.11.1522 ↗
26. Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves10.1016/j.yjmcc.2010.12.005 ↗
27. Mechanisms of calcification in aortic valve disease: role of mechanokinetics and mechanodynamics10.1007/s11886-013-0355-5 ↗
28. Human aortic valve calcification is associated with an osteoblast phenotype10.1161/01.CIR.0000070591.21548.69 ↗
29. Calcification of tissue heart valve substitutes: progress toward understanding and prevention10.1016/j.athoracsur.2004.06.033 ↗
30. Formation of monolayer films by the spontaneous assembly of organic thiols from solution onto gold10.1021/ja00183a049 ↗
31. Valvulogenesis: the moving target10.1098/rstb.2007.2130 ↗
32. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling10.1007/s00109-003-0456-5 ↗
33. Experimental and theoretical examination of surface energy and adhesion of nitrifying and heterotrophic bacteria using self-assembled monolayers10.1021/es101389u ↗
34. Contact-angle titrations of mixed omega-mercaptoalkaonic acid alkanethio monolayers on gold-reactive vs nonreactive spreading, and chain length effects of surface pKa values10.1021/la00022a048 ↗
35. Determination of the surface pK of carboxylic- and amine-terminated alkanethiols using surface plasmon resonance spectroscopy10.1021/la701760s ↗
36. Self-assembled monolayers with different terminating groups as model substrates for cell adhesion studies10.1016/j.biomaterials.2003.09.069 ↗
37. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion10.1002/jbm.a.10537 ↗
38. Effect of wettability and surface functional groups on protein adsorption and cell adhesion using well-defined mixed self-assembled monolayers10.1016/j.biomaterials.2007.03.013 ↗
39. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation10.1073/pnas.0407356102 ↗
40. Identification and characterization of calcifying valve cells from human and canine aortic valves
41. Phenotypic characterization of isolated valvular intersitial cell subpopulations
42. Using self-assembled monolayers to model the extracellular matrix10.1016/j.actbio.2009.01.016 ↗
43. Effect of surface potential on extracellular matrix protein adsorption10.1021/la5020362 ↗
44. Using self-assembled monolayers to understand the interactions of man-made surfaces with proteins and cells10.1146/annurev.bb.25.060196.000415 ↗
45. Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries10.1016/j.biomaterials.2004.11.028 ↗
46. Characterization of molecules mediating cell-cell communication in human cardiac valve interstitial cells10.1385/CBB:45:3:255 ↗
47. Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta(1) integrin viability signaling pathway10.1074/jbc.M313265200 ↗
48. Biophysical analysis of dystrophic and osteogenic models of valvular calcification10.1115/1.4029115 ↗
49. Elastic fibres10.1242/jcs.115.14.2817 ↗
50. Fibrillin assembly requires fibronectin10.1091/mbc.e08-08-0830 ↗
51. SPR studies of the nonspecific adsorption kinetics of human IgG and BSA on gold surfaces modified by self-assembled monolayers (SAMs)10.1006/jcis.1996.4586 ↗
52. Can valvular interstitial cells become true osteoblasts? a side-by-side comparison
53. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro10.1242/jcs.110.18.2187 ↗
54. Bone mineralization and osteoblast differentiation are negatively modulated by integrin alpha v beta 310.1359/jbmr.2001.16.2.277 ↗
55. Elastic and adhesive properties of alkanethiol self-assembled monolayers on gold10.1063/1.3111440 ↗
56. Proteomic analysis for the assessment of different lots of fetal bovine serum as a raw material for cell culture. Part IV. Application of proteomics to the manufacture of biological drugs10.1021/bp060121o ↗
57. The role of vitronectin in the attachment and spatial distribution of bone-derived cells on materials with patterned surface chemistry10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T ↗
58. Controlling osteopontin orientation on surfaces to modulate endothelial cell adhesion10.1002/jbm.a.30221 ↗
59. In vitro models of aortic valve calcification: solidifying a system10.1016/j.carpath.2014.08.003 ↗
60. Characterization of porcine aortic valvular interstitial cell ‘calcified’ nodules10.1371/journal.pone.0048154 ↗